AGC
AZN icon

August Group Capital’s AstraZeneca AZN Stock Holding History

August Group Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Sell
1,753
-218
-11% -$41K 0.37% 57
2026
Q1 		$389K Buy
1,971
+131
+7% +$25.3K 0.45% 46
2025
Q4 		$338K Buy
+1,840
New +$323K 0.38% 59

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

August Group Capital's AZN Position: Q2 2026 in Review

August Group Capital reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $41K and leaving 1,753 shares worth $332K. The position accounts for 0.37% of the portfolio, ranked #57.

August Group Capital first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $389K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • August Group Capital held 1,753 shares of AstraZeneca worth $332K as of Q2 2026.
  • August Group Capital sold 218 AstraZeneca shares in Q2 2026, an estimated $41K.
  • AstraZeneca made up 0.37% of August Group Capital's portfolio in Q2 2026, its #57 holding.
  • August Group Capital first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • August Group Capital's AstraZeneca position peaked at $389K in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on August Group Capital's 13F filing for Q2 2026, filed 11 Aug 2026.